Issue | Pharma's Almanac

Current Issue: Q4 2015

The Growing Role of Innovative Technologies

Also In This Issue

Innovative Strategies to Meet Today’s Changing Equipment Needs

Dramatic changes in the pharmaceutical industry are driving pressures to lower the time and costs of drug development, manufacturing, and packaging. Manufacturers and their contract service providers are looking to improve efficiency, eliminate redundancies, and rapidly increase pipelines. Significant company consolidation is resulting in considerable surplus equipment, driving growth for the used -equipment market. Contractors […]

Digital Automation in Clinical Trials: The Promise and Potential

The use of mobile technologies and basic clinical electronic data capture (EDC) systems, both of which are encouraged by the Food and Drug Administration (FDA), is helping to streamline the clinical trial process and reduce costs. More advanced, integrated cloud-based platforms are achieving further gains with Web-based tools that track drug supply, manage images, coordinate […]

Outsourcing Provides Advantages to Sponsor Companies

The pharmaceutical contract manufacturing industry is undergoing some important changes that reflect the current evolution of the pharmaceutical industry. An emphasis on cost control, a shift in growth from mature to emerging markets, the rising importance of generics and other low-cost drugs, the switch from large-volume blockbusters to small-volume targeted therapies, and the increasing potency […]

Risk Minimization through Careful CDMO Selection

The pharmaceutical industry is experiencing a period of significant change. Cost-cutting, downsizing, thinning pipelines, a lack of blockbusters, and the move to more biopharmaceutical — and in particular biosimilar — development, are leading many manufacturers to increase their reliance on contract development and manufacturing organizations (CDMOs). At the same time, because uncertainty creates risk, manufacturers […]

What Does It Mean to be a Full-Service CDMO?

Numerous trends in the pharmaceutical industry are driving drug manufacturers to outsourcing more activities, from discovery through commercial production and even life cycle management. In many cases they are looking for a combination of specialized expertise and integrated project management combined with cost-effective services. As a result, they are turning to true full-service contract development […]

Ensuring the Integrity of Temperature-Sensitive Drugs Along the Cold Chain: What You Can Do To Mitigate Risk

Dramatic changes in the pharmaceutical industry are forcing manufacturers to find better solutions to ensure the integrity of temperature-sensitive products along the cold chain. From shipments of active ingredients to clinical trial materials and finished products, even a minor temperature excursion during transit can have dire consequences for drug sponsors, patients and other stakeholders. An […]

Choosing the Optimal Drug Delivery System to Meet Patient Needs

For the last three decades, the challenge of poor medication adherence has been discussed by the healthcare industry, while the rates and associated costs of non-adherence continue to rise. Medication non-adherence is a significant risk to patient safety and substantially elevates the cost of care. Children, seniors, and many chronically ill patients are more prone […]

In-depth Process and Product Expertise – This is Key to CDMO Support of Orphan Drug and Breakthrough Therapy Development & Commercialization

As older blockbuster drugs lose patent protection and generic competition increases, many pharmaceutical companies are focusing discovery efforts on therapies with the potential to treat multiple niche populations. Increasingly, innovative small and emerging pharma firms are developing new drug candidates with orphan or breakthrough therapy status that are ultimately licensed or sold to large brand […]

Bolstering Capabilities for Parenteral Drug Development and Manufacturing

As the pharmaceutical and biotechnology markets undergo significant changes, companies are relying more heavily on CROs and CMOs to provide the needed services, expertise, and technologies to help them favorably compete in a challenging marketplace. Contract service providers, in turn, are strengthening their capabilities to satisfy current demands, in some cases by coming together. An […]

Be Innovative! Maneuvering the Global Pharmaceutical Market

The recent spike of patent cliffs has made a huge dent in pharma sales revenue. To recoup the loss and sustain market position, pharma companies are in the race for new drugs. The hunt for the next blockbuster has shifted away from small molecules towards biologics. Biotech companies are leading the drug discovery efforts, especially […]

Past Issues

View all Past Issues

The Business Development Issue

View Issue »

Issue #1 | Volume #5 | Q1 2019

Innovative & Expert Partners

View Issue »

Issue #2 | Volume #2 | Q2 2016

The Growing Role of Innovative Technologies

View Issue »

Issue #1 | Volume #1 | Q4 2015

The Role of Innovative Technologies

View Issue »

Issue #4 | Volume #3 | Q4 2017